Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DY5FX1
|
|||
| Drug Name |
VAC85135
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Myeloproliferative neoplasm [ICD-11: 2A20; ICD-10: D47.7] | Phase 1 | [1] | |
| Company |
JOHNSON & JOHNSON
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05444530) A Phase 1 Study of VAC85135, a Neoantigen Vaccine Regimen, Concurrently Administered With Ipilimumab for the Treatment of Myeloproliferative Neoplasms. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.